miR-346, miR-125a-5p, and miR-27a are all upregulated in cHL and might therefore contribute to the decrease in antigen presentation in cHL cases without genomic aberrations in the HLA class I and B2M genes. This evidence concerns the gene B2M and classic Hodgkin lymphoma.